These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 752309)

  • 1. In vitro degradation of mouse, rabbit and dog antibodies to Vibrio cholerae by succus entericus.
    Horsfall DJ; Heddle RJ; Gormly AA; Rowley D
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):681-93. PubMed ID: 752309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The source of IgM and IgG in the dog intestine.
    Heddle RJ; Rowley D
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):713-25. PubMed ID: 752310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae.
    Heddle RJ; Rowley D
    Immunology; 1975 Jul; 29(1):197-208. PubMed ID: 1140826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective properties of anticholera antibodies in human colostrum.
    Majumdar AS; Ghose AC
    Infect Immun; 1982 Jun; 36(3):962-5. PubMed ID: 7095856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Vibrio cholerae toxoid on the levels of antibodies of the IgG, IgA and IgM classes in rabbits].
    Aleksandrowicz J; Kudelski Z
    Med Dosw Mikrobiol; 1986; 38(1):15-22. PubMed ID: 3713366
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the biological properties of different classes of human antibodies in relation to cholera.
    Majumdar AS; Ghose AC
    Infect Immun; 1981 Apr; 32(1):9-14. PubMed ID: 7216497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motility of the pathogen and intestinal immunity of the host in experimental cholera.
    Yancey RJ; Berry LJ
    Adv Exp Med Biol; 1978; 107():447-55. PubMed ID: 742500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments.
    Steele EJ; Chaicumpa W; Rowley D
    J Infect Dis; 1975 Aug; 132(2):175-80. PubMed ID: 1159322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and biological properties of three classes of rabbit antibody to Vibrio cholerae.
    Steele EJ; Chaicumpa W; Rowley D
    J Infect Dis; 1974 Aug; 130(2):93-103. PubMed ID: 4842331
    [No Abstract]   [Full Text] [Related]  

  • 14. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies.
    Pierre P; Langendries A; Vaerman JP
    Immunol Lett; 1988 May; 18(1):51-5. PubMed ID: 3378829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses of rats to live Vibrio cholerae: antibodies in serum and intestinal secretions.
    Cooper GN; Jackson GD
    Parasite Immunol; 1981; 3(1):57-68. PubMed ID: 7220079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.
    Blanco LP; Dirita VJ
    Infect Immun; 2006 Dec; 74(12):6957-64. PubMed ID: 17000721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of methods for measuring intestinal antibodies against Vibrio cholerae in mice.
    Horsfall DJ; Rowley D
    Aust J Exp Biol Med Sci; 1979 Feb; 57(1):61-73. PubMed ID: 475670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.
    Heddle RJ; Knop J; Steele EJ; Rowley D
    Immunology; 1975 Jun; 28(6):1061-6. PubMed ID: 1093969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model.
    Mukhopadhyay S; Nandi B; Ghose AC
    FEMS Microbiol Lett; 2000 Apr; 185(1):29-35. PubMed ID: 10731603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.